Sole Source: Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits
Defense Health Agency · DEFENSE HEALTH AGENCY HCD WEST
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT941026N0054 in this department, oldest first.
- May 4, 2026 · this noticeSpecial Notice
- May 30, 2026Award NoticeILLUMINA, INC. · $273KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Notice of Intent to Sole Source HT941026N0054 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division � West (HCD-W), intends to award a firm fixed price purchase order for Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits for the Department of Clinical Investigation (DCI), Tripler Army Medical Center, Hawaii, in accordance with the Federal Acquisition Regulation Revolutionary (FAR) … (show all)
Overhaul 12.102(a): ILLUMINA, INC. 5200 Illumina Way San Diego, CA 92122 UEI: KMW3CRWNAAF3 The North American Industry Classification System (NAICS) code for this requirement is 541714, Research and Technology in Biotechnology (except Nanobiotechnology); the business size standard is 1,000 (in employees). The Product Service Code (PSC) is 6550, Medical Equipment and Accessories and Supplies. The objective of this sole source award is to procure one (1) Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP), (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A, (1) Respiratory Pathogen ID/AMR Enrichment Kit Set B, (8) PhiX Control v3, (9) NextSeq�1000/2000 P1 XLEAP-SBS Reagents, (10) MiSeq i100 Plus 50M Reagent Kit, (5) Illumina DNA Prep, Tagmentation, (2) Illumina DNA/RNA UD Indexes Set B (9) NextSeq 1000/2000 P2 XLEAP-SBS Reagents, (1) Illumina Respiratory Virus Enrichment Kit Set A, (1) Illumina Respiratory Virus Enrichment Kit Set B, (1) Illumina Respiratory Virus Enrichment Kit Set D, (1) Respiratory Virus Oligos Panel V2, (2) MiSeq i100 Plus 100M Reagent Kit, (16) MiSeq i100 25M Reagent Kit, (1) Illumina DNA/RNA UD Indexes Set C, (1) Illumina DNA/RNA UD Indexes Set D and (1) Illumina Respiratory Virus Enrichment Kit Set C for Tripler Army Medical Center. Illumina, Inc., is the only vendor that makes sequencing supplies for the DCI Government-owned MiSeq Systems. These sequencing supplies are specific for the Government-owned MiSeq System. There is no reasonable expectation of receiving quotes from two or more small businesses. The proposed acquisition strategy is to justify as an Other Than Full and Open procurement on a sole source basis. Delivery Date: 1 September 2026 Delivery Location: Tripler Army Medical Center, Department of Clinical Investigation, 1 Jarrett White Road, Bldg 40, Tripler AMC, HI 96859-5000 Illumina, Inc., is the only source that can meet the Government�s minimum requirements to provide the requested UPIP for DCI at Tripler Army Medical Center, HI. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required equipment and preventive maintenance. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Bobbie Dobberstein at bobbie.s.dobberstein.ctr@health.mil. The closing date for challenges is no later than 1000 Pacific Daylight Time, Thursday, May 7, 2026. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY HCD WEST), same product/service code (PSC) 6550.
Single-winner award sizes (10): middle half $246K to $1.6M, median $468K; range $111K to $4.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $2.8M | Oct 1, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $4.7M | Apr 8, 2026 |
| SAN DIEGO BLOOD BANK San Diego CA 92102 USA | 1 | $1.9M | Jun 22, 2025 |
| LIFESTREAM BLOOD BANK San Bernardino CA 92408 USA | 1 | $650K | Feb 24, 2025 |
| SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR | 1 | $604K | Jun 11, 2026 |
| ARKRAY MARKETING, INC. | 1 | $332K | Nov 14, 2025 |
| WERFEN USA LLC | 1 | $308K | Aug 19, 2026 |
| METRO MEDICAL EQUIPMENT & SUPPLY, INC. | 1 | $226K | Feb 7, 2025 |
| SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1 | $171K | Apr 16, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR EffortNo listed company matched (Materiality N/A)
- Aug 19, 2026WERFEN USA LLC$308KImmunohematology Reagents NMCSDNo listed company matched (Materiality N/A)
- Jun 11, 2026SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR$604KHematology and Coagulation AnalyzersNo listed company matched (Materiality N/A)
- Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCPNo listed company matched (Materiality N/A)
- Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHHNo listed company matched (Materiality N/A)
- Nov 14, 2025ARKRAY MARKETING, INC.$332KArkray Urine AnalyzersNo listed company matched (Materiality N/A)
- Jun 22, 2025SAN DIEGO BLOOD BANK San Diego CA 92102 USA$1.9MNaval Medical Center San Diego Blood Products BPANo listed company matched (Materiality N/A)
- Apr 16, 2025SIEMENS HEALTHCARE DIAGNOSTICS INC.$171KCPRR Reagents, Controls, and Consumables for Coagulation Testing at NHTPNo listed company matched (Materiality N/A)
- Feb 24, 2025LIFESTREAM BLOOD BANK San Bernardino CA 92408 USA$650KBLOOD BANK BPANo listed company matched (Materiality N/A)
- Feb 7, 2025METRO MEDICAL EQUIPMENT & SUPPLY, INC.$226KMEDICAL PLATELETSNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (9 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.